Adstiladrin

nadofaragene firadenovec-vcng

Approval

ApplicationBLA 125700
Approval dateDec 16, 2022
Approval year2022
SponsorFerring Pharmaceuticals A/S

FDA-approved use

High-grade, Bacillus Calmette-Guerin (BCG) unresponsive non-muscle invasive bladder cancer

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Adstiladrin: